Professor James Galloway is experienced in clinical trials in the field of rheumatology, having been chief investigator for both early and late-phase trials.
His background includes experience in early-phase drug development, including in healthy volunteer studies.
James is also a Honorary Consultant Rheumatologist at King’s College Hospital NHS Foundation Trust and Senior Director for the GKT School of Medical Education at King’s College London.